Theranos is reportedly stopping its signature blood-testing method

Laboratory startup Theranos has reportedly stopped using finger pricks to collect blood samples for all except one of its tests, under pressure from federal regulators, The Wall Street Journal reports.

That follows months of scrutiny $US10 billion Theranos and its CEO, Elizabeth Holmes, have faced regarding its signature blood-testing method, which was thought to potentially revolutionise that industry.

You can read all about the Theranos controversy via Tech Insider

NOW WATCH: Kesha sued her producer for sexual assault, and she says it’s destroying her career

NOW WATCH: Tech Insider videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.